Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at the use of the CA125 blood test to help monitor women with advanced ovarian cancer

Overview

Cancer types:

Ovarian cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at whether the CA125 blood test was a reliable way to measure if new treatments for ovarian cancer were working or not. This trial was supported by Cancer Research UK.

The trial was for women who had

  • Ovarian cancer

  • Primary peritoneal cancer

  • Fallopian tube cancer

These cancers are treated in the same way, so when we use the term ovarian cancer in this summary, we are referring to all of these.

Recruitment start: 1 December 2003

Recruitment end: 27 November 2011

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Gordon Rustin

Supported by

Cancer Research UK

East and North Hertfordshire NHS Trust

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUKE/04/014.

Last reviewed: 25 Nov 2013

CRUK internal database number: 544

Help and support